Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production

Diabetes

Volumn 51, Issue 2, 2002, Pages 311-316

  Thomas, Helen E ^a   Darwiche, Rima ^a   Corbett, John A ^b   Kay, Thomas W H ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INSULIN; INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 0036068246     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2.311     Document Type: Article

References (41)

1. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
2. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
3. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus
4. Virus-induced autoimmnne diabetes: Most β-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes
5. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci
6. Cellular and molecular changes accompanying the progression from insulitis to diabetes
7. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice
8. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes
9. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide
10. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis
11. IL-1-alpha, 1L-1-beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes
12. The role of Fas in autoimmune diabetes
13. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
14. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
15. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells
16. Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside
17. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase
18. IL-1 produced and released endogenously within human islets inhibits beta cell function
19. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes
20. Endothelial cells as cytotoxic effector cells: Cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide
21. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes
22. Bovine serum albumin density gradient isolation of rat pancreatic islets
23. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
24. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
25. Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells
26. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent
27. Contribution of ductal cells to cytokine responses by human pancreatic islets
28. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans
29. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans
30. Inhibition of insulin secretion by intefieukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism
31. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase
32. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: Prevention by dexamethasone
33. -/-)
34. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets: Protection by arginine analogs and/or coencapsulated erythrocytes
35. Distinction between interleukin-1-induced necrosis and apoptosis of islet cells
36. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
37. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha
38. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes
39. Dual role of interferon-gamma signalling pathway in sensitivity of pancreatic beta cells to immune destruction
40. Cell death mediators in autoimmune diabetes: No shortage of suspects
41. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays